CN1060085C - 'Kangruling' medicine mixture - Google Patents
'Kangruling' medicine mixture Download PDFInfo
- Publication number
- CN1060085C CN1060085C CN98102359A CN98102359A CN1060085C CN 1060085 C CN1060085 C CN 1060085C CN 98102359 A CN98102359 A CN 98102359A CN 98102359 A CN98102359 A CN 98102359A CN 1060085 C CN1060085 C CN 1060085C
- Authority
- CN
- China
- Prior art keywords
- type
- mixture
- cyclomastopathy
- chinese patent
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a novel Chinese patent medicine for treating cyclomastopathy, namely, a 'Kangruling' medicine mixture. With the start of regulating endocrine functions and on the basis of using the medicaments for invigorating the kidney, benefiting vital energy, regulating thoroughfares and conception vessels, relieving liver qi stagnation and softening and resolving hard masses as fundamental compounding materials, the medicaments are adjusted according to different states of diseases and symptoms, and the medicine in the form of oral medicinal liquid is extracted from Chinese patent medicines with different compounding by the modern technology and is divided into different types aiming at corresponding symptoms. The present invention comprises type I, type II and type III which are respectively used for treating pain type, pain-lump type and lump type cyclomastopathy. The 'Kangruling' medicine mixture has the advantages of good therapeutic effect, high cure rate, convenient use, etc.
Description
The present invention relates to the field of Chinese medicines, be particularly for a kind of Chinese patent medicine mixture for the treatment of cyclomastopathy.Be applicable to the cyclomastopathy of the various symptoms of treatment, the state of an illness, also can be as the prevention of breast carcinoma and the rehabilitation medication of breast carcinoma postoperative.
Cyclomastopathy is higher commonly encountered diseases, the frequently-occurring disease of popular a kind of sickness rate in the middle of the women, and normal not obvious because of therapeutic effect, the easy treatment that makes cyclomastopathy that shows effect repeatedly becomes the problem that medical circle is relatively paid close attention to.The Drug therapy of cyclomastopathy has two kinds of Chinese medicine and western medicine at present, and Chinese medicine has multiple, and have asparagine sheet, RUPIXIAO, breast commonly used increase Chinese patent medicines such as peaceful, and Western medicine is many with androgen or tamoxifen etc.Existing these Chinese patent medicine dispersing the stagnated live-QI to relieve the stagnation of QI, heat-clearing and toxic substances removing, the pain that disappears of invigorating blood circulation have certain curative effect to breast disease.But because these Chinese patent medicines mostly are to provide a drug matching, all be to use the fixedly good a kind of magistral medicines of compatibility promptly to cyclomastopathy dissimilar, symptom, therefore, in application, can not well realize symptomatic treatment, have deficiencies such as cure rate is low, easy recurrence.The hormone drug class goes out to send treatment from the hormonal balance of adjusting the patient, and certain curative effect is arranged, and brings toxic and side effects but take easily for a long time to the patient, and patient is difficult for accepting.
The objective of the invention is to disclose a kind of based on effect a permanent cure, the Chinese patent medicine mixture for the treatment of both the principal and secondary aspects of a disease, the good effect of suiting the remedy to the case, treatment cyclomastopathy that cure rate is high.
Design of the present invention is the theoretical mechanism with the combination of Chinese and Western medicine, breast disease is carried out researching and analysing of etiology and pathogenesis, adopt the kidney invigorating to transfer and dash appoint, modulability hormonal balance and the traditional Chinese medical science distinguishes the method that the disease differential diagnosis of diseases combines, the new Chinese patent medicine of breast disease of a kind for the treatment of both the principal and secondary aspects of a disease of research preparation.
Task of the present invention be at insufficiency of kidney-YANG on this basis, by cyclomastopathy, prepare that the way of different medicines realizes to dissimilar, different symptoms, the different state of an illness.
Cyclomastopathy is to increase relevant with periodicity disorder of hormone secretion, mammary gland tissue to the sensitivity of hormone.Be relative or definitely too high, the long-time stimulus mammary gland tissue of estrogen luteal phase, and progestogen again hyposecretion lose due to the protective effect.Therefore, the present invention makes it should meet theory of Chinese medical science when medication, the kidney invigorating, soothing the liver, strongly fragrant, the softening the hard mass that looses, treating both the principal and secondary aspects of a disease.Have the effect of the adjusting hormonal balance of Western medicine again, improve endocrine, thereby reach better therapeutic effect, the unlikely again toxic and side effects of bringing.
" The liver and the kidney have a common source " insufficiency of kidney-YANG is this, is the theoretical foundation of medication of the present invention.Deficiency of kidney-QI, Chong and Ren channel disorder are for falling ill originally, and depression of liver-QI, the expectorant stasis of blood stagnate and be the mark of morbidity, deficiency of kidney-QI, the liver failing to be nourished, and the dredging of liver rushed down functional disorder, and stagnation of QI collection forms nodules of the breast with fixed attention.Therefore the present invention starts with from endocrine regulation, provided tonify Qi of the kidney, the Chinese medicine of the Chinese medicine of regulating thoroughfare and controlling vessel and dispersing the stagnated live-QI to relieve the stagnation of QI, hard masses softening and resolving, constituted basic compatibility of the present invention, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Technical characterictic of the present invention is to change the way that existing Chinese patent medicine with a kind of part is used for the cyclomastopathy of the different state of an illness, different symptoms, but according to the difference of morbidity process, symptom, typing has been prepared different prescriptions on the basis of basic compatibility.Concrete Chinese patent medicine mixture is divided into I type, II type and three kinds of models of III type.Wherein the I type is a painful, and the II type is that pain adds swollen type, and the III type is the lump type, and being respectively applied for treatment pain is the master, the pain lump is concurrent and lump is the cyclomastopathy of three kinds of different symptoms of master.Basic compatibility of the present invention be by tonify Qi of the kidney, regulating thoroughfare and controlling vessel, dispersing the stagnated live-QI to relieve the stagnation of QI, the Herba Epimedii that improves endocrine function, Cornu Cervi Degelatinatum, Rhizoma Cyperi, Radix Bupleuri; The drug matchings such as Squama Manis, Semen Vaccariae, Medulla Tetrapanacis, Concha Ostreae that improve iodine products Sargassum, the Thallus Laminariae (Thallus Eckloniae) of luteal function, dissipating phlegm and resolving masses and the lactogenesis of invigorating blood circulation, hard masses softening and resolving, reducing swelling and alleviating pain constitute.The drug matching of three kinds of models is to have carried out the adjustment and the increase and decrease of medicine according to the difference of the state of an illness, symptom on the basis of basic compatibility, and typing has been mixed with the Chinese patent medicine of three kinds of different compatibilities.Chinese patent medicine facilitates patients in order to make, absorption and instant effect, and what the wood invention provided is to make the oral liquid mixture with modern crafts to form.Also can make the Chinese patent medicine of other forms such as pill, capsule, tablet or decoction as required.
The present invention is owing to start with from balance hormone, adjustment endocrine function, at the different state of an illness and symptom, typing prepared based on tonify Qi of the kidney, the Chinese patent medicine mixture of three kinds of models of regulating thoroughfare and controlling vessel, dispersing the stagnated live-QI to relieve the stagnation of QI, hard masses softening and resolving, make that medicine has that the property of suiting the medicine to the illness is strong, good effect, be difficult for advantage such as recurrence.
Specific embodiments of the invention are as follows:
Embodiment 1
I type Chinese patent medicine mixture
I type treatment pain type, what be mainly used in that the treatment stagnation of QI due to depression of the liver causes is the cyclomastopathy of cardinal symptom with pain, its drug matching is as follows:
Herba Epimedii 10~20g, Cornu Cervi Degelatinatum 10~15g, Rhizoma Cyperi 10~15g, Radix Bupleuri 10~15g, Thallus Laminariae (Thallus Eckloniae) 15~20g, Sargassum 15~20g, Radix Rhapontici 10~15g, Semen Vaccariae 15~20g, Squama Manis 10~15g, Concha Ostreae 30g, Medulla Tetrapanacis 5~10g, Rhizoma Chuanxiong 10~15g, Radix Curcumae 10~15g, the Radix Paeoniae Alba 10~15g.
The Chinese patent medicine that the drink form that becomes to be convenient to absorb is refined in medicinal modern crafts preparation in the above-mentioned compatibility gets final product (Chinese patent medicine that also can be made into forms such as pill, capsule, tablet, decoction).
I type herb mixture is on the basis of basic compatibility of the present invention, assistant matches with Radix Curcumae, the Radix Paeoniae Alba and Rhizoma Cyperi, Radix Bupleuri, constituted the drug matching of dispersing the stagnated live-QI to relieve the stagnation of QI, to symptom for, breast distension painful based on breast, lump be cannot find out or menstruation before pain increase the weight of, lump increases, pain relief, lump dwindle disappearance after the menstruation, and the cyclomastopathy of the chest and back pain of accompanying has significant curative effect.
Embodiment 2
II type Chinese patent medicine mixture
II type treatment pain adds the lump type, is mainly used in treatment pain and the simultaneous cyclomastopathy of lump.Its drug matching is as follows:
Herba Epimedii 15~20g, Cornu Cervi Degelatinatum 10~20g, Rhizoma Cyperi 10~15g.Radix Bupleuri 10~15g, Thallus Laminariae (Thallus Eckloniae) 15~20g, Sargassum 15~20g, Semen Vaccariae 15~20g, Concha Ostreae 30g, Medulla Tetrapanacis 5~10g, Radix Paeoniae Rubra 10~15g, Squama Manis 10~15g, rhizoma sparganic 15~20g, Rhizoma Curcumae 15~20g, Spina Gleditsiae 15~20g.
Above-mentioned drug matching is refined into oral liquid mixture form with the modern crafts preparation get final product (also can be made into forms such as pill, capsule, tablet or decoction).
II type herb mixture is adjusted on the basis of basic compatibility of the present invention, and assistant forms with compatibility of drugss such as the Radix Paeoniae Rubra of blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, rhizoma sparganic, Rhizoma Curcumae, Spina Gleditsiae.To symptom is that pain and lump exist simultaneously, with the cyclomastopathy of soreness of waist cold extremities, dizziness, menoxenia significant curative effect is arranged.
Embodiment 3
III type Chinese patent medicine mixture
III type treatment lump type is mainly used in the cyclomastopathy of treatment based on lump, and its compatibility is as follows:
Radix Scrophulariae 10~20g, Herba Epimedii 10~20g, Cornu Cervi Degelatinatum 10~15g, Thallus Laminariae (Thallus Eckloniae) 10~20g, Sargassum 10~20g, Semen Vaccariae 10~20g, Squama Manis 10~15g, rhizoma sparganic 10~20g, Rhizoma Curcumae 10~20g, Spina Gleditsiae 10~20g, Bulbus Fritillariae Thunbergii 10~15g.
Refine into oral liquid mixture form with the modern crafts preparation, also can prepare the Chinese patent medicine of forms such as pill, tablet, decoction or capsule.
III type Chinese patent medicine mixture is to have adjusted the dispersing the stagnated live-QI to relieve the stagnation of QI medicine on the basis of the basic compatibility of the present invention, has increased the compatibility of Radix Scrophulariae, Bulbus Fritillariae Thunbergii formation hard masses softening and resolving, coordinates to work with blood circulation promoting and blood stasis dispelling such as rhizoma sparganic, Rhizoma Curcumae, Spina Gleditsiae, hard masses softening and resolving medicine.More rope or lamellar agglomerate appear in, one or both sides lax to cardinal symptom performance renal deficiency type such as breast, with the menstruation variation, the cyclomastopathy that pain does not show has significant curative effect to the lump size.III type Chinese patent medicine mixture also can be as the ancillary drug of Breast Cancer Prevention rehabilitation.
According to the Chinese patent medicine mixture of above embodiment preparation, owing to realized typing dispenser to the ill, good effect not only, the cure rate height, and greatly facilitate the treatment of the world of medicine to cyclomastopathy, have a extensive future.Moreover, the present invention is according to the typing of state of an illness symptom, the way of classification, also for the science that improves the treatment by Chinese herbs cyclomastopathy, policy-making, realizes that the computer management of Chinese traditional treatment lays the foundation.
Claims (2)
1, the Chinese patent medicine mixture of treatment cyclomastopathy is characterized in that this mixture makes 3 kinds of model I, II, III type according to the cyclomastopathy different state of an illness and symptom, and this mixture is a drink form, wherein:
A, I type treatment pain type: make as active component raw material by following:
Herba Epimedii 10~20g, Cornu Cervi Degelatinatum 10~15g, Rhizoma Cyperi 10~15g, Radix Bupleuri 10~15g, Thallus Laminariae (Thallus Eckloniae) 15~20g, Sargassum 15~20g, Radix Rhapontici 10~15g, Semen Vaccariae 15~20g, Squama Manis 10~15g, Concha Ostreae 30g, Medulla Tetrapanacis 5~10g, Rhizoma Chuanxiong 10~15g, Radix Curcumae 10~15g, the Radix Paeoniae Alba 10~15g.
B, II type treatment pain add the lump type: made as active component raw material by following:
Herba Epimedii 15~20g, Cornu Cervi Degelatinatum 10~20g, Rhizoma Cyperi 10~15g, Radix Bupleuri 10~15g, Thallus Laminariae (Thallus Eckloniae) 15~20g, Sargassum 15~20g, Semen Vaccariae 15~20g, Concha Ostreae 30g, Medulla Tetrapanacis 5~10g, Radix Paeoniae Rubra 10~15g, Squama Manis 10~15g, rhizoma sparganic 15~20g, Rhizoma Curcumae 15~20g, Spina Gleditsiae 15~20g.
C, III type treatment lump type: make as active component raw material by following:
Radix Scrophulariae 10~20g, Herba Epimedii 10~20g, Cornu Cervi Degelatinatum 10~15g, Thallus Laminariae (Thallus Eckloniae) 10~20g, Sargassum 10~20g, Semen Vaccariae 10~20g, Squama Manis 10~15g, rhizoma sparganic 10~20g, Rhizoma Curcumae 10~20g, Spina Gleditsiae 10~20g, Bulbus Fritillariae Thunbergii 10~15g.
2, the described Chinese patent medicine mixture of claim 1 is characterized in that this mixture can be mixed with dosage forms such as pill, tablet, capsule, decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98102359A CN1060085C (en) | 1998-06-08 | 1998-06-08 | 'Kangruling' medicine mixture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98102359A CN1060085C (en) | 1998-06-08 | 1998-06-08 | 'Kangruling' medicine mixture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1198941A CN1198941A (en) | 1998-11-18 |
| CN1060085C true CN1060085C (en) | 2001-01-03 |
Family
ID=5217290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98102359A Expired - Fee Related CN1060085C (en) | 1998-06-08 | 1998-06-08 | 'Kangruling' medicine mixture |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1060085C (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1086131C (en) * | 1999-08-20 | 2002-06-12 | 张四岩 | A kind of pharmaceutical composition for treating mammary gland hyperplasia |
| CN1075386C (en) * | 1999-09-03 | 2001-11-28 | 聂翠新 | Method for producing Anruneixiao medicinal liquid |
| CN100389815C (en) * | 2006-05-26 | 2008-05-28 | 雷秋模 | Medicine for treating mammary glands hyperplasia |
| CN100361669C (en) * | 2006-05-30 | 2008-01-16 | 王怀民 | A Chinese medicinal preparation for treating mammary glands hyperplasia |
| CN101224290B (en) * | 2007-12-28 | 2010-07-14 | 李显成 | Chinese traditional medicine for treating breast nodules and preparing method thereof |
| CN101732528B (en) * | 2010-02-10 | 2011-06-22 | 李蕴 | Chinese medicament for treating of hyperplasia of mammary gland |
| CN102205071B (en) * | 2011-05-28 | 2012-07-04 | 吴汉利 | Chinese medicinal composition for treating thyroid cyst |
| CN103656532A (en) * | 2013-12-27 | 2014-03-26 | 丁丽 | Traditional Chinese medicine formula for treating breast hyperplasia |
| CN104435645A (en) * | 2014-12-17 | 2015-03-25 | 张瑞荣 | Traditional Chinese medicinal composition applied after breast cancer operation and preparation method of traditional Chinese medicinal composition |
-
1998
- 1998-06-08 CN CN98102359A patent/CN1060085C/en not_active Expired - Fee Related
Non-Patent Citations (5)
| Title |
|---|
| 中国中西医结合杂志1997年17卷第2期 1997.2.20 信国峰等,乳结平治疗腺增生病105例临床疗效0观察 * |
| 山东医药工业1995,14,1 1919.9.5 李守俟等,乳宁合剂的制备300例临床观察 * |
| 河北中医1992,14,2 1919.9.2 霸效,化淤消核治疗乳腺增生病54例 * |
| 河北中医1992,14,2 1919.9.2 霸效,化淤消核治疗乳腺增生病54例;山东医药工业1995,14,1 1919.9.5 李守俟等,乳宁合剂的制备300例临床观察;陕西中医1989.10,4 1919.8.9 张忠,中药治疗乳腺增生96例;中国中西医结合杂志1997年17卷第2期 1997.2.20 信国峰等,乳结平治疗腺增生病105例临床疗效0观察 * |
| 陕西中医1989.10,4 1919.8.9 张忠,中药治疗乳腺增生96例 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1198941A (en) | 1998-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101934025B (en) | Traditional Chinese medicine for clearing away heat and toxic material | |
| CN102631513B (en) | Medicinal plaster for removing stasis, eliminating stagnation and relieving swelling and preparation method thereof | |
| CN104826016B (en) | A kind of pharmaceutical composition and its preparation method and application for treating the proliferation of mammary gland | |
| CN1060085C (en) | 'Kangruling' medicine mixture | |
| CN101502609B (en) | Chinese medicament preparation for cooling blood and dissolving stasis | |
| CN100371012C (en) | Medicinal composition, and its preparing method and use | |
| CN101095933A (en) | Chinese traditional medicine compound recipe for healing bones and treating wound | |
| CN1063088C (en) | Medicine for curing hepatic and gallbladder diseases | |
| CN101810744A (en) | Formula of orally-taken Chinese medicament for treating hyperplasia of mammary glands | |
| CN102670895A (en) | Chinese medicinal composition for treating joint traumatic synovitis and preparation method thereof | |
| CN101461851A (en) | Chinese herbal medicine for treating hyperosteogeny | |
| CN100427134C (en) | A Chinese traditional medicinal composition for treatment of cholecystitis | |
| CN1186083C (en) | Chinese medicine for treating mammary gland foliole proliferation | |
| CN111388543A (en) | Traditional Chinese medicine composition for treating gout and preparation and application thereof | |
| CN102552740B (en) | Chinese medicine for curing gynecological inflammations and preparation method thereof | |
| CN100398143C (en) | Medicament for treating vitiligo | |
| CN1261146C (en) | Plaster for treating hyperplasia of mammary glands | |
| CN1698736A (en) | Externally applied medicine for treating mammary glands hyperplasia and preventing mammary cancer | |
| CN101757355A (en) | Traditional Chinese medicine preparation for treating infertility | |
| CN100364596C (en) | Compounded mongolia medicine for treating diabetes and preparing method | |
| CN105770478A (en) | Traditional Chinese medicine composition for treating bladder cancer | |
| CN1356128A (en) | Chinese medicine for treating rheumatic and rheumatoid diseases | |
| CN101040919B (en) | Chinese traditional medicine for treating cholecystitis | |
| CN104825720A (en) | Traditional Chinese medicine composition for treating dysmenorrhoea | |
| CN1278434A (en) | Tumor pain relieving ointment and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1048338 Country of ref document: HK |
|
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |